Establishment of a New Human Pneumococcal Standard Reference Serum, 007sp
| Autor: | Milan S. Blake, R. Burton, Nathalie Durant, Kathrin U. Jansen, J. Raab, Charles E. Rose, J. Lin, L. Lee, Lindsey Ashton, Ian M. Feavers, L. Katz, Brian D. Plikaytis, Daniel S. Schmidt, David Goldblatt, Peter C. Giardina, Sandra Romero-Steiner, Philip Fernsten, Moon H. Nahm, L. Kierstead, Mustafa Akkoyunlu, George M. Carlone, Joseph M. Antonello, R. Care, F. Fievet, Jean-François Maisonneuve, Jack T. Stapleton |
|---|---|
| Rok vydání: | 2011 |
| Předmět: |
Microbiology (medical)
Serotype Hepatitis C virus Clinical Biochemistry Immunology Enzyme-Linked Immunosorbent Assay medicine.disease_cause Polysaccharide Vaccine Vial Pneumococcal conjugate vaccine Pneumococcal Vaccines Streptococcus pneumoniae medicine Humans Immunology and Allergy Hepatitis B virus biology business.industry Reference Standards Vaccine Research Antibodies Bacterial Virology Human Experimentation biology.protein Antibody business medicine.drug |
| Zdroj: | Clinical and Vaccine Immunology. 18:1728-1736 |
| ISSN: | 1556-679X 1556-6811 |
| DOI: | 10.1128/cvi.05252-11 |
| Popis: | Lot 89SF has been the reference standard serum pool used in pneumococcal enzyme-linked immunosorbent assays (ELISAs) since 1990. In 2005, it was estimated that there remained between 2 and 5 years' supply of lot 89SF. Since lot 89SF was the reference standard used in the evaluation of the seven-valent pneumococcal conjugate vaccine Prevnar (PCV7), the link to clinical efficacy would be severed if stocks became completely depleted. Furthermore, demonstration of immune responses comparable to those elicited by PCV7 is a licensure approach used for new pneumococcal conjugate vaccines, so a replacement reference standard was required. A total of 278 volunteers were immunized with the 23-valent unconjugated polysaccharide vaccine Pneumovax II, and a unit of blood was obtained twice within 120 days following immunization. Plasma was prepared, pooled, and confirmed to be free from hepatitis B virus (HBV), hepatitis C virus (HCV), and HIV. The pooled serum was poured at 6 ml per vial into 15,333 vials and lyophilized. Immunological bridging of 007sp to 89SF was used to establish equivalent reference values for 13 pneumococcal capsular serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F) by five independent laboratories. Antibody concentrations in 007sp were established relative to the lot 89SF reference preparation using the WHO reference ELISA. Subsequently, 12 existing WHO calibration sera had concentrations reassigned for 13 pneumococcal serotypes using new serum 007sp as the reference, and these were compared to concentrations relative to the original reference serum. Agreement was excellent for the 12 WHO calibration sera. The 007sp preparation has replaced 89SF as the pneumococcal reference standard. Sufficient quantity of this new preparation is available such that, with judicious use, it should be available for at least 25 years. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|